Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of INBRX-109 (ozekibart) compared to placebo in adults with unresectable or metastatic chondrosarcoma – a rare bone cancer

    Not recruiting

    2 1 1
    France Germany Ireland Italy The Netherlands Spain
  • Study Comparing Lenalidomide, Bortezomib, Dexamethasone, Isatuximab, and Iberdomide for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Spain
  • Study on the Safety and Effectiveness of Luveltamab Tazevibulin (STRO-002) for Infants and Children Under 12 with Acute Myeloid Leukemia (AML)

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Denmark France Germany Italy The Netherlands +1
  • Study on Managing High Cholesterol in Cardiovascular Disease Patients Using Inclisiran

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Hungary
  • Study on the Safety of Avelumab for Patients with Solid Tumors Continuing Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria France Hungary Italy Poland Romania +1
  • Study on Talazoparib and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    Belgium Czechia Finland France Germany Hungary +6
  • Study Comparing Anakinra and Prednisone for Treating Gout Flare in Patients with Advanced Kidney Disease or Kidney Transplant

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on Tulisokibart for Treating Moderate to Severe Crohn’s Disease in Adults

    Not recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Croatia Czechia Denmark Finland +15
  • Study of Cobolimab and Dostarlimab for Children and Young Adults with Newly Diagnosed or Relapsed/Refractory Tumors

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    Czechia Denmark France Germany Italy Spain
  • Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Austria Bulgaria Croatia Czechia Denmark France +10